Medication de‐escalation opportunities among frail older adults with strictly‐controlled cardiometabolic disease.

The article presents a study which reported the proportion of frail older adults on medications despite having strictly-controlled disease. Topics include percentage of older adults with a frail phenotype and strictly-controlled disease remaining on medication for their cardiometabolic disease, limitations of the study, and rationale for studying how de-escalation of medications in older adults with frailty and strictly-controlled cardiometabolic disease affects outcomes and satisfaction.